Preparation of 5'-O-(1-Thiotriphosphate)-Modified Oligonucleotides Using Polymerase-Endonuclease Amplification Reaction (PEAR (original) (raw)
Polymerase-Endonuclease Amplification Reaction (PEAR) for Large-Scale Enzymatic Production of Antisense Oligonucleotides
Shuang-yong Xu
PLoS ONE, 2010
View PDFchevron_right
We Should Continue the Half-Century History of Applications of Antisense Oligonucleotides in Medicine, Agriculture and Forestry: A Mini-Review
Anna Repetskaya
View PDFchevron_right
Recent advances in synthesis of modified oligonucleotides
Prasanta K Ghosh
Zenodo (CERN European Organization for Nuclear Research), 2000
View PDFchevron_right
Design and applications of modified oligonucleotides
Mariana Gallo
Brazilian Journal of Medical and Biological Research, 2003
View PDFchevron_right
Modified oligonucleotides: IV solid phase synthesis and preliminary evaluation of phosphorothioate RNA as potential antisense agents
Francois Morvan
Tetrahedron Letters, 1990
View PDFchevron_right
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Karishma Dhuri
Journal of Clinical Medicine
View PDFchevron_right
A Half-Century History of Applications of Antisense Oligonucleotides in Medicine, Agriculture and Forestry: We Should Continue the Journey
Anna Repetskaya
View PDFchevron_right
Antisense oligonucleotides: recent progress in the treatment of various diseases
magharla dasaratha Dhanaraju
Beni-Suef University Journal of Basic and Applied Sciences, 2022
View PDFchevron_right
Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
Joselyn Rivera
Borneo Journal of Pharmacy
View PDFchevron_right
The therapeutic potential of antisense oligonucleotides
Ramaswamy Narayanan
BioEssays, 1995
View PDFchevron_right
Novel Antisense and Peptide Nucleic Acid Strategies for Controlling Gene Expression
Dwaine Braasch
Biochemistry, 2002
View PDFchevron_right
Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 24-54-ribo- and 34-54-deoxyribonucleotide segments
adrienne manning
View PDFchevron_right
Oligonucleotides: Current Trends and Innovative Applications in the Synthesis, Characterization, and Purification
Daniela Perrone
Biotechnology Journal, 2020
View PDFchevron_right
MODIFIED OLIGONUCLEOTIDES: Synthesis and Strategy for Users
Sandeep Verma
Annual Review of Biochemistry, 1998
View PDFchevron_right
Antisense Oligonucleotide: Basic Concept and its Therapeutic Application
Dr Bharti Bhandari Rathore
View PDFchevron_right
Therapeutic implications of antisense oligonucleotides
M. Mazzei
International Journal of Clinical & Laboratory Research, 1992
View PDFchevron_right
Antisense oligonucleotide technologies in drug discovery
Tarek Aboul-fadl
Expert opinion on drug discovery, 2006
View PDFchevron_right
Sugar modified oligonucleotides I. Carbo-oligodeoxynucleotides as potential antisense agents
Michel Perbost
Biochemical and Biophysical Research Communications, 1989
View PDFchevron_right
Synthesis of branched antisense oligonucleotides having multiple specificities
Marvin Rubenstein
Medical Hypotheses, 2006
View PDFchevron_right
Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals
Guillermo Vasquez
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Functionalization of the 3′-Ends of DNA and RNA Strands with N-ethyl-N-coupled Nucleosides: A Promising Approach To Avoid 3′-Exonuclease-Catalyzed Hydrolysis of Therapeutic Oligonucleotides
Montserrat Terrazas, Ignacio Faustino, Ramon Eritja, Modesto Orozco
ChemBioChem, 2013
View PDFchevron_right
3′-3′-linked oligonucleotides: Synthesis and stability studies
Carole Chaix
Bioorganic & Medicinal Chemistry Letters, 1996
View PDFchevron_right
In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3′ and 5′ thiophosphate linkages
Erich Koller
Nucleic Acids Research, 2019
View PDFchevron_right
Recent Advances in Oligonucleotide Synthesis and Their Applications
Vaijayanthi Bhashyam
ChemInform, 2004
View PDFchevron_right
5'-,3'-Inverted Thymidine-modified Antisense Oligodeoxynucleotide Targeting Midkine. ITS DESIGN AND APPLICATION FOR CANCER THERAPY
Hiroshi Itoh
Journal of Biological Chemistry, 2002
View PDFchevron_right
Antisense Oligonucleotides Containing Conformationally Constrained 2′,4′-( N -Methoxy)aminomethylene and 2′,4′-Aminooxymethylene and 2′- O ,4′- C -Aminomethylene Bridged Nucleoside Analogues Show Improved Potency in Animal Models
Punit Seth
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Comparison of the RNase H cleavage kinetics and blood serum stability of the North-conformationally constrained and 2'-alkoxy modified oligonucleotides
Jyoti Chattopadhyaya
Biochemistry, 2007
View PDFchevron_right